InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Reshma Kewalramani, CEO & President, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 16 open-market SEC Form 4 transactions: 2 purchases worth $3.4M and 14 sales worth $62.7M, reported from Aug 19, 21 to Feb 27, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 27, 26 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 15.6K | $496.95 | $7.7M |
| Aug 6, 25 | VRTXVERTEX PHARMACEUTICALS INC / MA | BUY | 5.7K | $389.95 | $2.2M |
| Nov 8, 24 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 15.2K | $515.00 | $7.8M |
| Jul 30, 24 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 15.2K | $505.00 | $7.7M |
| Jul 22, 24 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 15.2K | $497.00 | $7.6M |
| May 24, 24 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 1.6K | $457.00 | $715K |
| May 20, 24 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 15.2K | $447.00 | $6.8M |
| Dec 15, 23 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 17.1K | $407.00 | $7.0M |
| Dec 13, 23 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 5.1K | $397.00 | $2.0M |
| Nov 13, 23 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 5.1K | $377.00 | $1.9M |
| Jul 17, 23 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 7.8K | $355.00 | $2.8M |
| Apr 27, 23 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 1.7K | $340.19 | $566K |
| Jan 25, 23 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 10.0K | $315.05 | $3.2M |
| Aug 15, 22 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 11.7K | $305.06 | $3.6M |
| Jun 24, 22 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 11.7K | $291.30 | $3.4M |
| Aug 19, 21 | VRTXVERTEX PHARMACEUTICALS INC / MA | BUY | 5.8K | $196.34 | $1.1M |